We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 21-40 of 10,000 results
  1. Effect of adjuvant radiotherapy on overall survival and breast cancer-specific survival of patients with malignant phyllodes tumor of the breast in different age groups: a retrospective observational study based on SEER

    Purpose

    Malignant phyllodes tumor of the breast (MPTB) is a rare type of breast cancer, with an incidence of less than 1%. The value of adjuvant...

    ** Yang, Gongyin Zhang, ... Li Lv in Radiation Oncology
    Article Open access 21 May 2024
  2. Modeling breast cancer survival and metastasis rates from moderate-sized clinical data

    Predicting time-dependent survival probability of a breast cancer patient using information such as primary tumor size, grade, node spread status,...

    Article 03 January 2021
  3. Real-world evidence of treatment patterns and survival of metastatic gastric cancer patients in Germany

    Background

    Patients with metastatic gastric cancer (mGC) have poor prognosis. This real-world study aimed to describe treatment regimens and survival...

    Jaime Luna, Nils Picker, ... Thorsten Oliver Götze in BMC Cancer
    Article Open access 13 April 2024
  4. Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trial

    Background

    Patients with ruptured gastrointestinal stromal tumour (GIST) have poor prognosis. Little information is available about how adjuvant...

    Heikki Joensuu, Annette Reichardt, ... Peter Reichardt in British Journal of Cancer
    Article Open access 11 June 2024
  5. Association between pathologic response and survival after neoadjuvant therapy in lung cancer

    Neoadjuvant immunotherapy plus chemotherapy improves event-free survival (EFS) and pathologic complete response (0% residual viable tumor (RVT) in...

    Julie Stein Deutsch, Ashley Cimino-Mathews, ... Janis M. Taube in Nature Medicine
    Article Open access 30 October 2023
  6. Causes of death and effect of non-cancer-specific death on rates of overall survival in adult classic Hodgkin lymphoma: a populated-based competing risk analysis

    Background

    The improved prognosis of classic Hodgkin lymphoma (cHL) has been accompanied by elevated risks of non–cancer-specific death (non-CSD). The...

    Jie Gao, Yingying Chen, ... Yongqian Jia in BMC Cancer
    Article Open access 25 August 2021
  7. Prediction of survival and analysis of prognostic factors for hepatocellular carcinoma: a 20-year of imaging diagnosis in Upper Northern Thailand

    Background

    To evaluate survival rates of hepatocellular carcinoma (HCC), the Chiang Mai Cancer Registry provided characteristics data of 6276 HCC...

    Nawapon Nakharutai, Imjai Chitapanarux, ... Wittanee Na Chiangmai in BMC Cancer
    Article Open access 04 November 2023
  8. Retrospective evaluation of the contribution of radiotherapy to survival in breast cancer treatment with propensity score based on stage and subgroup

    Background

    Breast cancer has been a disease in which treatment strategy has changed over time under the influence of different hypotheses and evidence...

    Rusen Cosar, Necdet Sut, ... Sernaz Topaloglu in Radiation Oncology
    Article Open access 26 June 2024
  9. Oxidative damage in the gastrocnemius predicts long-term survival in patients with peripheral artery disease

    Patients with peripheral artery disease (PAD) have increased mortality rates and a myopathy in their affected legs which is characterized by...

    Panagiotis Koutakis, Hernan Hernandez, ... Iraklis I. Pipinos in npj Aging
    Article Open access 05 April 2024
  10. Lenalidomide in combination with R-CHOP produces high response rates and progression-free survival in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma: results from the Phase 2 MC078E study

    Diffuse large B-cell lymphoma (DLBCL), either concurrent with or transformed from follicular lymphoma (FL) is often excluded from clinical trials....

    Sanjal H. Desai, Betsy LaPlant, ... Grzegorz S. Nowakowski in Blood Cancer Journal
    Article Open access 25 September 2021
  11. Lower disease control rates and survival outcomes among Blacks with pharyngeal squamous cell carcinomas compared with Whites: a retrospective analysis at the University of Florida

    Disparate clinical outcomes for pharyngeal squamous cell carcinoma (PSCC) of the oropharynx (OPSCC) and hypopharynx (HPSCC) have been observed in...

    Kristianna M. Fredenburg, Joan Whitlock, ... William M. Mendenhall in Cancer Causes & Control
    Article 14 July 2021
  12. Excellent survival in relapsed stage I testicular cancer

    Background

    Two thirds of patients with germ-cell cancer (GCC) present as clinical stage I (CSI). Following orchiectomy, active surveillance (AS) has...

    Philip Speicher, Christian D. Fankhauser, ... Dilara Akhoundova in BMC Cancer
    Article Open access 15 September 2023
  13. Survival of advanced/recurrent gastrointestinal stromal tumors treated with tyrosine kinase inhibitors in Taiwan: a nationwide registry study

    Background

    Most gastrointestinal stromal tumors (GISTs) harbor c-KIT or PDGFRA mutations. Administration of tyrosine kinase inhibitors (TKIs) has...

    Hui-Jen Tsai, Yan-Shen Shan, ... Tsang-En Wang in BMC Cancer
    Article Open access 11 July 2024
  14. Survival of cervical cancer patients at Moi teaching and Referral Hospital, Eldoret in western Kenya

    Background

    Cervical cancer is a major health burden and the second most common cancer after breast cancer among women in Kenya. Worldwide cervical...

    E. Mwaliko, P. Itsura, ... M. Temmerman in BMC Cancer
    Article Open access 13 November 2023
  15. No evidence to support the impact of migration background on treatment response rates and cancer survival: a retrospective matched-pair analysis in Germany

    Background

    Immigration has taken the central stage in world politics, especially in the developed countries like Germany, where the continuous flow of...

    Roman Rüdiger, Franziska Geiser, ... Ingo G. H. Schmidt-Wolf in BMC Cancer
    Article Open access 10 May 2021
  16. Effect of different surgical approaches on the survival and safety of Siewert type II esophagogastric junction adenocarcinoma: a systematic review and meta-analysis

    Background

    Whether a transthoracic (TT) procedure by a thoracic surgeon or a transabdominal (TA) by a gastrointestinal surgeon is best for Siewert...

    Hongyang Zheng, **ngmei Yin, ... Zhenjia Li in BMC Cancer
    Article Open access 21 November 2023
  17. Renin-angiotensin system inhibitors improve the survival of cholangiocarcinoma: a propensity score-matched cohort study

    Background

    Hypertension is a risk factor for cholangiocarcinoma (CCA). The effect of anti-hypertensive drugs on the prognosis of CCA is not clear.

    ...
    **ao-Xu Zhu, Jian-Hui Li, ... **ao-Yu Yin in BMC Cancer
    Article Open access 05 September 2023
  18. Preoperative IL-8 levels as prognostic indicators of overall survival: an extended follow-up in a prospective cohort with colorectal liver metastases

    Introduction

    CRC with liver metastases is a major contributor to cancer-related mortality. Despite advancements in liver resection techniques, patient...

    Mathieu Pecqueux, Frederik Brückner, ... Christoph Kahlert in BMC Cancer
    Article Open access 17 January 2024
  19. A joint international consensus statement for measuring quality of survival for patients with childhood cancer

    The aim of treating childhood cancer remains to cure all. As survival rates improve, long-term health outcomes increasingly define quality of care....

    Rebecca J. van Kalsbeek, Melissa M. Hudson, ... Lisa Zwiers in Nature Medicine
    Article 15 June 2023
  20. Use of period analysis to provide a timely assessment of 5-year relative survival for pancreatic cancer patients from Taizhou, eastern China

    Assessing long-term tumor survival rates is crucial for evaluating the effectiveness of tumor treatment and burden. However, timely assessment of...

    Ye Lu, Min He, ... **fei Chen in BMC Cancer
    Article Open access 10 July 2023
Did you find what you were looking for? Share feedback.